Medtech companies take heed, as Chinese corruption clampdown spreads
This article was originally published in Clinica
Executive Summary
Medtech companies doing business in China would do well to conduct a special internal audit as Chinese authorities intensify their scrutiny on inappropriate conduct within the healthcare industry.